Acetylcysteine/Bethanechol Chloride

乙酰半胱氨酸/氯化氨甲酰甲胆碱

Report date: 2022/01/24 09:15:49

Base Information

Drug NameAcetylcysteine/Bethanechol Chloride
Drug Alias Name氯化氨甲酰甲胆碱/乙酰半胱氨酸Acetylcysteine+Bethanechol Chloride乙酰半胱氨酸+氯化氨甲酰甲胆碱Bethanechol chloride/acetylcysteine氯化氨甲酰甲胆碱+乙酰半胱氨酸 +[7] 
ClassificationSmall molecules
Mechanisms of ActionFree radicals inhibitorsMuscarinic acetylcholine receptor M2 agonists
TargetsMuscarinic acetylcholine receptor M2Free radicals
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AcetylcysteineBethanechol Chloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDiamedica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiamedica
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A